SCHEMBL17538513

SCHEMBL17538513

Cc1cc(NC(=O)c2ccccc2C(=O)O)n[nH]1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNA2 P20248 2/20 0.71
▸ CDK2 P24941 2/20 0.71
▸ CCNA1 P78396 2/20 0.71
▸ ALPL P05186 1/20 0.68
▸ ALPI P09923 1/20 0.68
▸ MEN1 O00255 2/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ KDM4E B2RXH2 2/20 0.57
▸ L3MBTL1 Q9Y468 2/20 0.57
▸ NPC1 O15118 5/20 0.57
▸ RAB9A P51151 5/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ ATM Q13315 1/20 0.56
▸ ALDH1A1 P00352 3/20 0.51
▸ POLB P06746 2/20 0.51
▸ CYP1A2 P05177 2/20 0.51
▸ BRD4 O60885 1/20 0.51
▸ CREBBP Q92793 1/20 0.51
▸ RET P07949 1/20 0.51
▸ LMNA P02545 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8141305 0.83 CCNA2 (1.00) CCNA2CDK2CCNA1MEN1KMT2A
SCHEMBL25143450 0.83 CCNA2 (0.63) CCNA2CDK2CCNA1ALPLALPI
SCHEMBL31665052 0.83 CCNA2 (0.63) CCNA2CDK2CCNA1ALPLALPI
SCHEMBL6341557 0.78 CCNA2 (0.85) CCNA2CDK2CCNA1ALPLNPC1
SCHEMBL6339700 0.77 CCNA2 (0.82) CCNA2CDK2CCNA1MEN1KMT2A
SCHEMBL9132190 0.76 CCNA2 (0.66) CCNA2CDK2CCNA1MEN1KMT2A
SCHEMBL6339310 0.76 NPC1 (0.66) CCNA2CDK2CCNA1KDM4ENPC1
SCHEMBL23825508 0.76 SORT1 (0.74) KMT2AATMALDH1A1POLBHPGD
SCHEMBL29980451 0.76 SORT1 (0.74) KMT2AATMALDH1A1POLBHPGD
SCHEMBL4725839 0.74 CCNA2 (0.63) CCNA2CDK2CCNA1ALPLALPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11045476-B2 Compounds and methods for inducing chondrogenesis THE SCRIPPS RESEARCH INSTITUTE (US) 2021-06-29 — — US disclosed
US-20200188407-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS THE SCRIPPS RESEARCH INSTITUTE 2020-06-18 — — US disclosed
US-9452170-B2 Compounds and methods for inducing chondrogenesis THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2016-09-27 — — US disclosed
US-20160045514-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2016-02-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11045476-B2 Compounds and methods for inducing chondrogenesis COL2A1, BMP4, COL1A1 CCNA2 350/4885CDK2 280/4885CCNA1 368/4885
US-20160045514-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS COL2A1, BMP4, COL1A1 CCNA2 350/4885CDK2 280/4885CCNA1 368/4885
US-20200188407-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS COL2A1, BMP4, COL1A1 CCNA2 350/4885CDK2 280/4885CCNA1 368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback